Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Eli Lilly’s mirikizumab shows promise in phase 3 Crohn’s disease study

Inflammatory bowel disease affects almost one in every 100 people in the US

- PMLiVE

Merck and Exelixis partner to evaluate new cancer combination treatments

The companies will evaluate the regimens in head and neck cancer and renal cell carcinoma

- PMLiVE

FDA advisory committee recommends Stealth’s elamipretide for Barth syndrome

The ultra-rare genetic disease affects approximately 150 people in the US

- PMLiVE

Innovative Trials appoints new Leadership Team member

Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director

Innovative Trials

- PMLiVE

Mtech Access are exhibiting at ISPOR in Europe

• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat...

Petauri Evidence

- PMLiVE

TOMORROW: Last chance to register for FREE Origins Webinar: How Patient Involvement is Transforming Clinical Trials – Reserve Your Spot Today!

Last chance to register for our exclusive webinar, “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!   Wendy Erler and Alfred Samuels are ready to join Su Smith and...

Origins – The Patient Focused Specialists

- PMLiVE

Johnson & Johnson receives updated NICE recommendation for Tecvayli in multiple myeloma

Approximately 5,900 new cases of the blood cancer are diagnosed every year in the UK

- PMLiVE

Pfizer shares positive phase 3 results for Talzenna combination in prostate cancer

Up to 20% of patients will develop metastatic castration-resistant disease within five to seven years of diagnosis

- PMLiVE

Roche presents two-year data for spinal muscular atrophy treatment Evrysdi in children

The severe and progressive neuromuscular disease affects about one in every 10,000 babies

- PMLiVE

Eli Lilly and insitro collaborate to advance new treatments for metabolic diseases

Metabolic dysfunction-associated steatotic liver disease is estimated to affect 100 million people in the US

- PMLiVE

GSK’s RSV vaccine Arexvy shown to protect older adults across three seasons

The respiratory virus is estimated to impact 64 million people globally every year

- PMLiVE

Roche’s Itovebi combination granted FDA approval for advanced breast cancer

Approximately 310,720 women will be diagnosed with invasive breast cancer in the US this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links